The United Bio-Technology (Hengqin) Co., Ltd.

10 registered trials on this site, 8 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.

Compounds covered

UBT251

Registered trials

Trial	Compound	Phase	Status	Sponsor	Enrolled	Primary completion	Registry updated
UBT251 Injection Phase Ⅲ Study (OSA-PAP) NCT07806851	UBT251	Phase 3	Not yet recruiting	The United Bio-Technology (Hengqin) Co., Ltd.	150	Mar 2029	Sep 8, 2026
UBT251 Injection Phase Ⅲ Study (OSA-NPAP) NCT07767942	UBT251	Phase 3	Not yet recruiting	The United Bio-Technology (Hengqin) Co., Ltd.	150	Sep 2028	Aug 25, 2026
Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity NCT07785934	UBT251	Phase 1	Recruiting	The United Bio-Technology (Hengqin) Co., Ltd.	48	Dec 2026	Aug 25, 2026
UBT251 Injection Phase II Clinical Study (CKD) NCT07134335	UBT251	Phase 2	Recruiting	The United Bio-Technology (Hengqin) Co., Ltd.	180	Jul 11, 2030	Nov 25, 2025
A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) NCT07145151	UBT251	Phase 2	Recruiting	The United Bio-Technology (Hengqin) Co., Ltd.	156	Jun 4, 2027	Nov 20, 2025
UBT251 Injection Phase II Study (Overweight or Obesity) NCT07177469	UBT251	Phase 2	Completed	The United Bio-Technology (Hengqin) Co., Ltd.	205	Oct 22, 2025	Not stated
UBT251 Injection Phase II Study in Type 2 Diabetes, With Semaglutide Comparator NCT07163624	UBT251	Phase 2	Completed	The United Bio-Technology (Hengqin) Co., Ltd.	211	Nov 21, 2025	Not stated
UNIGUIDE-1: UBT251 Phase 3 in Type 2 Diabetes on Diet and Exercise Alone NCT07659574	UBT251	Phase 3	Recruiting	The United Bio-Technology (Hengqin) Co., Ltd.	360	Sep 24, 2027	Not stated
UNIGUIDE-2: UBT251 Phase 3 Against Semaglutide in Type 2 Diabetes NCT07653477	UBT251	Phase 3	Recruiting	The United Bio-Technology (Hengqin) Co., Ltd.	956	Feb 29, 2028	Not stated
UBT251 Phase 3 in Overweight or Obesity (China) NCT07648225	UBT251	Phase 3	Not yet recruiting	The United Bio-Technology (Hengqin) Co., Ltd.	600	Sep 29, 2027	Not stated

Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.

The United Bio-Technology (Hengqin) Co., Ltd.

The United Bio-Technology (Hengqin) Co., Ltd.

Compounds covered

Registered trials

Explore

Beginner guides

Research areas

Tools and pipeline